Theseus Pharmaceuticals (NASDAQ:THRX) reported quarterly losses of $(0.30) per share. This is a 95.6 percent increase over losses of $(6.82) per share from the same period last year.
Elon Musk Agrees With Chamath Palihapitiya On Fiscal Policies, Jamie Dimon Warns Of Potential Rate Hike, Peter Schiff Challenges Jerome Powell’s Inflation Outlook And More: Top Economics Update This Week
This week has been quite a rollercoaster in the financial world. From critical analysis of the U.S. Treasury’s…